Clinical outcomes from the Assessing Donor-derived cell-free DNA Monitoring Insights of kidney Allografts with Longitudinal surveillance (ADMIRAL) study

Authors

Lihong Bu, University of Minnesota - Twin Cities
Haris Murad, Washington University School of Medicine in St. Louis
Tarek Alhamad, Washington University School of Medicine in St. Louis
et al.

Journal

Kidney International

Publication Date

4-1-2022

Volume

101

Issue

4

First Page

793

Last Page

803

Document Type

Open Access Publication

DOI

10.1016/j.kint.2021.11.034

Rights and Permissions

Bu L, Gupta G, Pai A, Anand S, Stites E, Moinuddin I, Bowers V, Jain P, Axelrod DA, Weir MR, Wolf-Doty TK, Zeng J, Tian W, Qu K, Woodward R, Dholakia S, De Golovine A, Bromberg JS, Murad H, Alhamad T. Clinical outcomes from the Assessing Donor-derived cell-free DNA Monitoring Insights of kidney Allografts with Longitudinal surveillance (ADMIRAL) study. Kidney Int. 2022 Apr;101(4):793-803. doi: 10.1016/j.kint.2021.11.034. Copyright 2021, International Society of Nephrology. Published by Elsevier Inc. This is an open access article under the CC BY license (http:// creativecommons.org/licenses/by/4.0/).

Recommended Citation

Bu, Lihong; Murad, Haris; Alhamad, Tarek; and et al., "Clinical outcomes from the Assessing Donor-derived cell-free DNA Monitoring Insights of kidney Allografts with Longitudinal surveillance (ADMIRAL) study." Kidney International. 101, 4. 793 - 803. (2022).
https://digitalcommons.wustl.edu/oa_4/1548

Department

ICTS (Institute of Clinical and Translational Sciences)

Additional Links

Supplemental material is available for this article at publisher site.